Skip to Content

Tian'an Pharmaceutical Co Ltd TNPH

Morningstar Rating
$0.01 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TNPH is trading at a 47% premium.
Price
$0.01
Fair Value
$3.29
Uncertainty
Extreme
1-Star Price
$8.86
5-Star Price
$8.36
Economic Moat
Sqnm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TNPH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.01
Market Cap
$92,366.01
Volume/Avg
9,000 / 9,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tian'an Pharmaceutical Co Ltd is engaged in investing, advising and building businesses in the sustainability sector, including in the health and wellness, education, sustainability, food and agriculture, fintech, e-commerce, tourism and consumer sectors.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
126
Website

Valuation

Metric
TNPH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TNPH
Quick Ratio
13.28
Current Ratio
14.23
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
TNPH
Return on Assets (Normalized)
23.83%
Return on Equity (Normalized)
25.27%
Return on Invested Capital (Normalized)
25.07%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
BbdrbdgkxqNcpw$82.1 Bil
Merck KGaA ADR
MKKGY
BfbkddthtLqwfym$75.2 Bil
Haleon PLC ADR
HLN
XhksxltGptzr$41.4 Bil
Viatris Inc
VTRS
KpkbhndrtCrwkw$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
HyhgtrjNzn$13.7 Bil
Catalent Inc
CTLT
XtmchrmnMzrbd$10.6 Bil
Perrigo Co PLC
PRGO
LsyptvyrZgvq$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
TzlmtvvvsLrbkj$3.5 Bil
Curaleaf Holdings Inc
CURLF
NwsbrzcDfrs$3.0 Bil
Green Thumb Industries Inc
GTBIF
XmhylgbspcBskz$2.7 Bil

Sponsor Center